Loading stock…

Baxter International Inc. (BAX) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Baxter International Inc.

BAXMarket cap $12BPrice $24.0

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Equipment

Makes IV fluids, dialysis machines, and hospital equipment that keep critical care running worldwide. Nearly every U.S. hospital relies on its products daily, and a single 2023 hurricane knocked out a key plant, causing a national shortage of IV fluids.

In Bastion Portfolios?

52W Return+4%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+4%4

Revenue Forecast

Rev CAGR (1y)+3%4

Rev CAGR (3y)+3%2

Rev CAGR (5y)+3%3

Earnings Forecast

EPS Growth Y+10%5

EPS Growth Y+2-1%3

EPS Growth Y+3+7%6

Quality

Margins

EBIT Margin8%4

Net Income Margin-9%1

Free Cash Flow Margin7%5

Debt

Net Debt/EBITDA3.82

Efficiency

ROE-14%1

ROA-5%1

Earnings Stability44

GEAR+VERY WEAK10

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)128

P/E Ratio (Forward 3y)117

P/BV2.07

EV Multiples

EV/EBITDA Fwd97

EV/EBIT Fwd137

Yield

Free Cash Flow Yield6.6%8

Dividend Yield0.2%1

Momentum

Short term

1 month return-4%6

3 month return+9%8

YTD return+26%8

Mid term

Price vs 52wHigh80%5

1 year return+6%5

Long term

3 year return-31%1

5 year return-67%1

Risk Shield

Price Risk

Beta1.13

Volatility44%4

Free Cash Flow

Free Cash Flow Margin7%5

Free Cash Flow Yield6.6%8

Quality

ROCE5%3

Earnings Stability44

Net Debt/EBITDA3.82

02Growth

Is it actually growing, and how fast?

BAXBaxter International

Revenue FY25$10.6B

GROWTH RATING↗

WEAK19 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+4%4

Revenue, next 1Y+3%4

Revenue, next 3Y, CAGR+3%2

Revenue, next 5Y, CAGR+3%3

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E-1%3

EPS growth, FY28E+7%6

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

Revenue grew 4%/yr over the last 3 years and is set to keep growing around 3%/yr.

WEAKNESSES

Growth is the weak spot here, trailing 81% of companies worldwide.

Revenue is set to grow 3%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to grow 3%/yr, behind 70% of companies worldwide.3/10

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Stalled Business

Growth is a weak point here. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK33 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-4%6

3-month return+9%8

YTD return+26%8

MID & LONG-TERM▾SCORE

% of 52-week high80%5

1-year return+6%5

3-year return-31%1

5-year return-67%1

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over three months (+9%) and so far this year (+26%).

WATCH

It's up 6% over the past year, but 20% below its 52-week high. That is right in line with the market.

Returns sit at the market level over the past month (-4%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-31% over three years and -67% over five), behind 90% of the market.

BOTTOM LINE

Early Turnaround

A poor multi-year track record but a sharp recent rally. Momentum is turning up, yet the trend is young and unproven — it needs follow-through to confirm rather than fade. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Baxter. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

BAXBaxter International

Revenue FY25$10.6B

GROWTH RATING↗

WEAK19 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+4%4

Revenue, next 1Y+3%4

Revenue, next 3Y, CAGR+3%2

Revenue, next 5Y, CAGR+3%3

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E-1%3

EPS growth, FY28E+7%6

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

Revenue grew 4%/yr over the last 3 years and is set to keep growing around 3%/yr.

WEAKNESSES

Growth is the weak spot here, trailing 81% of companies worldwide.

Revenue is set to grow 3%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to grow 3%/yr, behind 70% of companies worldwide.3/10

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Stalled Business

Growth is a weak point here. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK33 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-4%6

3-month return+9%8

YTD return+26%8

MID & LONG-TERM▾SCORE

% of 52-week high80%5

1-year return+6%5

3-year return-31%1

5-year return-67%1

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over three months (+9%) and so far this year (+26%).

WATCH

It's up 6% over the past year, but 20% below its 52-week high. That is right in line with the market.

Returns sit at the market level over the past month (-4%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-31% over three years and -67% over five), behind 90% of the market.

BOTTOM LINE

Early Turnaround

04Value

Are you paying a fair price for it?

Stop guessing on Baxter. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community